MRI引导下真空辅助空心针活检发现的高危乳腺病变:手术切除与影像随访结局
回顾性分析2007年1月至2012年7月99个9G MRI引导下真空辅助活检(MRI-VAB)高危病变,53个手术切除者中6个(11%)升级为浸润癌或导管原位癌(DCIS),ADH升级率19%(4/21),混合性ALH-LCIS中2例升级;46个保守随访者中位点无乳腺癌发生。作者认为ADH和混合性ALH-LCIS需手术切除,其他病变可多学科个体化管理。
要点
- MRI-VAB高危病变手术切除总体升级率11%(6/53),ADH为19%(4/21),混合性ALH-LCIS有2例升级。
- 仅影像随访的46个病变在MRI-VAB位点无乳腺癌发生证据。
- 作者认为ADH及混合性ALH-LCIS需手术切除,其他高危病变可多学科讨论个体化管理。
核心结论
- MRI-VAB高危病变手术切除升级率低;ADH和混合性ALH-LCIS需手术切除,其他病变可多学科讨论制定个体化管理方案。
研究设计与样本
- 回顾性研究,纳入2007年1月至2012年7月99个影像学一致的高危病变(90例患者),均经9G MRI引导下真空辅助活检,参考标准为手术组织病理或2年影像随访。
诊断标准与关键数值
- 53个手术切除病变中6个(11%)升级为浸润癌或DCIS。
- 21个ADH病变中4个(19%)升级为DCIS。
- 36个小叶肿瘤病变中2个(6%)升级为DCIS和浸润性小叶癌各1例,均为混合性ALH-LCIS。
- 46个保守随访病变中17个(37%)仅行乳腺X线摄影随访,29个(63%)行乳腺X线摄影联合MRI随访,MRI-VAB位点均无乳腺癌发生证据。
临床应用与阅片要点
- 作者认为ADH及混合性ALH-LCIS病变需手术切除。
- 作者认为其他高危病变可由多学科讨论决定个体化管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE:: To determine whether breast MRI-guided vacuum-assisted biopsy (MRI-VAB) high-risk lesion histology influences surgical or long-term imaging follow-up outcomes.
METHODS:: Patients with imaging-concordant high-risk findings on 9-gauge breast MRI-VAB between January 2007 and July 2012 who had surgical histopathology or 2 year imaging follow-up were retrospectively reviewed.
RESULTS:: 90 patients with 99 lesions were included. Lesions were atypical ductal hyperplasia (ADH) (n = 21), lobular neoplasia [n = 36; atypical lobular hyperplasia (ALH) (n = 22), lobular carcinoma in situ (LCIS) (n = 6), and ALH plus LCIS (n = 8)], and other high-risk lesion (n = 42; papillary lesions, radial scar, flat epithelial atypia, atypia unspecified). Of 53 excised lesions, 6 (11%) were upgraded to invasive cancer or ductal carcinoma in situ (DCIS). 4 of 21 (19%) ADH lesions were upgraded to DCIS. 2 of 36 (6%) lobular neoplasia lesions, both combined ALH and LCIS, were upgraded to DCIS, and invasive lobular carcinoma, respectively. The remaining 46 lesions were managed conservatively with imaging follow-up: 17 (37%) had mammography only, while 29 (63%) had mammography and MRI follow-up. There was no evidence of breast cancer development at the site of MRI-VAB in the cases with only imaging follow-up.
CONCLUSION:: We conclude that the upgrade rate for high-risk lesions at MRI-VAB at surgical excision is low. Surgical excision is warranted for ADH and combined ALH-LCIS lesions. For other lesions, a multidisciplinary approach to decide on personalized management may be appropriate.
ADVANCES IN KNOWLEDGE:: Surgical excision is warranted for ADH lesions and combined ALH-LCIS lesions identified at breast MRI-VAB. A multidisciplinary approach to patient management of other high-risk lesions may be appropriate.
引用
- Speer ME, Huang ML, Dogan BE, et al. High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up. Br J Radiol. 2018. PMID: 29947265. doi:10.1259/bjr.20180300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。